Segment Description: Joseph Eron, MD; Paul Sax, MD; W. David Hardy, MD; Eric S. Daar, MD; Ian Frank, MD, partake in a conversation on the importance of rapid treatment initiation, the difficulties of adherence, and accessibility.
…
Ian Frank, MD: So some of these issues are less important. We’re going to come back to U=U and as treatment as prevention. We want to get people on therapy quickly to get their viral load undetectable as rapidly as possible. But if somebody comes in and says, “I don’t think I’m ready to start this,” I don’t think we should be twisting their arm to get them to start on therapy.
W. David Hardy, MD: I agree with you that we shouldn’t twist their arm.
Joseph Eron, MD: You should talk them into it.
W. David Hardy, MD: From the prescriber’s side.